Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Clinicopathological analysis revealed that low Rap1GAP expression was significantly correlated with tumor size (p= 0.033), histological grade (p= 0.034), T classification (p= 0.012), N classification (p= 0.006) and clinical stage (p= 0.005).
|
29758923 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Decreased expression of Rap1GAP was significantly associated with depth of invasion, lymph node metastasis, advanced Tumor-Node-Metastasis stage and a poor prognosis in patients with CRC following surgery.
|
29725465 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In this study, the tumor suppressing activity of Rap1GAP in EAC was explored.
|
28196746 |
2017 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Rap1GAP is a crucial tumor suppressor, but its role in gastric cancer (GC) is little investigated.
|
28009991 |
2017 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The functional significance of the widespread down-regulation of Rap1 GTPase-activating protein (Rap1GAP), a negative regulator of Rap activity, in human tumors is unknown.
|
23864657 |
2013 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Rap1GAP is thought of as a putative tumor suppressor gene and plays an important role in human tumor progression including pancreatic cancer, thyroid cancer and melanoma.
|
22614916 |
2012 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The functional significance of decreased RAP1GAP protein expression in human tumors is unclear.
|
22696507 |
2012 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinoma.
|
21532618 |
2011 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The significance of the widespread downregulation of Rap1GAP in human tumors is unknown.
|
21785277 |
2011 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Loss of Rap1GAP expression correlated with tumor invasiveness but not with specific mutations activating the mitogen-activated protein kinase pathway.
|
20124489 |
2010 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The frequent downregulation of Rap1GAP in epithelial tumors where alterations in cell/cell and cell/matrix adhesion are early steps in tumor dissemination supports a role for Rap1GAP depletion in tumor progression.
|
20439492 |
2010 |
Neoplasms
|
0.100 |
PosttranslationalModification
|
group |
BEFREE |
Rap1GAP down-regulation is due to its promoter methylation, a mechanism of gene silencing in tumors.
|
19147557 |
2009 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Furthermore, SCC cells transfected with rap1GAP produced significantly smaller tumors in nude mice as compared to controls (P < 0.01).
|
16436672 |
2006 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Collectively, our data identify rap1GAP as a putative tumor suppressor gene in pancreatic cancer.
|
16424023 |
2006 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The retrovirally tagged genes Plekhb1, Prex1, Prkg2, Sox10 and 1200004M23Rik were upregulated in the tumors but had a different expression profile than Pdgfralpha whereas Rap1gap, Gli1, Neurl and Camk2b were downregulated in the tumors.
|
15750623 |
2005 |